+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Addison's Disease Testing Market by Test Type, End User, Technology, Distribution Channel, Sample Type, Patient Age Group - Global Forecast to 2030- Product Image
Addison's Disease Testing Market by Test Type, End User, Technology, Distribution Channel, Sample Type, Patient Age Group - Global Forecast to 2030- Product Image
Sale

Addison's Disease Testing Market by Test Type, End User, Technology, Distribution Channel, Sample Type, Patient Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015134
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Addison’s Disease Testing Market is at a pivotal point due to increasing clinical demands for precision and efficiency in diagnostics. As advances in endocrinology and shifting healthcare landscapes redefine patient care, industry leaders must recalibrate strategies to safeguard competitive positioning and tap into new growth vectors.

Market Snapshot: Addison’s Disease Testing Market

The Addison’s Disease Testing Market grew from USD 266.69 million in 2024 to USD 277.42 million in 2025. It is expected to continue growing at a CAGR of 3.95%, reaching USD 336.54 million by 2030. This momentum is driven by heightened awareness of adrenal insufficiency, increased adoption of innovative diagnostic modalities, and expanding demand for early, accurate detection. As a result, organizations are focused on integrating advanced biochemical assays, expanding imaging capabilities, and aligning diagnostic services with the needs of both centralized and decentralized care environments.

Scope & Segmentation

  • Test Types: Acth stimulation tests, cortisol measurement, dexamethasone suppression tests, imaging modalities, insulin-induced hypoglycemia testing
  • End Users: Ambulatory care settings, diagnostic laboratories, secondary hospitals, tertiary hospitals, research institutes
  • Technology: Lab-based automated and manual methods, point-of-care devices
  • Distribution Channels: Direct sales, distributors, online sales
  • Sample Types: Blood (plasma, serum), saliva (stimulated, whole), urine
  • Patient Age Groups: Adults, geriatrics, pediatrics
  • Geographic Regions: Americas (United States – California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, France, Germany, United Arab Emirates, South Africa, Israel, Nigeria, Switzerland, Poland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Singapore, Vietnam, Malaysia, Taiwan, Thailand, Philippines)
  • Companies Covered: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., bioMérieux SA, Ortho Clinical Diagnostics, Inc., DiaSorin S.p.A., Bio-Rad Laboratories, Inc., Fujirebio Inc.

Key Takeaways for Senior Decision-Makers

  • Diagnostic precision is rising as newer, high-sensitivity assays and automated stimulation testing platforms are adopted to streamline workflows in both hospital and outpatient settings.
  • The industry increasingly leverages artificial intelligence for image analysis, integrating anatomical and biochemical data for comprehensive diagnostic support.
  • Point-of-care devices, previously for preliminary use, are now gaining prominence in emergency and decentralized environments where rapid, accurate assessments are crucial.
  • Patient preference for noninvasive, telemedicine-compatible sample collection methods is driving further investment in saliva-based and home care-compatible solutions.
  • Regulatory adaptation is accelerating, with agencies refining guidelines for the validation of innovative systems, balancing oversight and market speed.
  • Leading players are forming strategic partnerships to consolidate expertise, access new technology, and maintain relevancy in competitive and evolving landscapes.

Tariff Impact: 2025 US Policy Shifts

Newly implemented US tariffs on imported diagnostic reagents and devices have led to cost increases for manufacturers dependent on overseas components. This is prompting reassessment of sourcing strategies, acceleration of domestic production, and exploration of supply chain resilience initiatives. Healthcare providers and reference labs are adapting, with some delaying capital investments in advanced analyzers and others turning to domestic vendors. Cross-industry collaboration is rising in response, with efforts to diversify supplier bases and address inventory risks. The imperative remains to maintain diagnostic accuracy and access despite these shifts.

Methodology & Data Sources

This report synthesizes market intelligence from structured interviews with clinicians, laboratory directors, and technology providers, combined with secondary sources such as peer-reviewed journals, regulatory filings, and corporate disclosures. Quantitative analyses were corroborated with proprietary databases and established market intelligence platforms, while qualitative themes were subjected to peer review to ensure data integrity and eliminate bias.

Why This Report Matters

  • Enables informed strategy around adoption of innovative diagnostic technologies in both established and emerging markets.
  • Clarifies evolving regulatory, reimbursement, and supply chain dynamics impacting procurement, capital allocation, and long-term planning.
  • Provides actionable segmentation insights to optimize service offering for distinct clinical environments and patient populations.

Conclusion

The Addison’s Disease Testing Market is transforming through technological, regulatory, and supply chain evolution. Senior leaders equipped with these insights can respond with confidence and secure lasting competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Addison's Disease Testing Market, by Test Type
8.1. Introduction
8.2. Acth Stimulation Test
8.3. Cortisol Measurement
8.4. Dexamethasone Suppression Test
8.5. Imaging
8.6. Insulin-Induced Hypoglycemia Test
9. Addison's Disease Testing Market, by End User
9.1. Introduction
9.2. Ambulatory Care Settings
9.3. Diagnostic Laboratories
9.4. Hospitals
9.4.1. Secondary Hospitals
9.4.2. Tertiary Hospitals
9.5. Research Institutes
10. Addison's Disease Testing Market, by Technology
10.1. Introduction
10.2. Lab-Based
10.2.1. Automated Methods
10.2.2. Manual Methods
10.3. Point-Of-Care
11. Addison's Disease Testing Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Online Sales
12. Addison's Disease Testing Market, by Sample Type
12.1. Introduction
12.2. Blood
12.2.1. Plasma
12.2.2. Serum
12.3. Saliva
12.3.1. Stimulated Saliva
12.3.2. Whole Saliva
12.4. Urine
13. Addison's Disease Testing Market, by Patient Age Group
13.1. Introduction
13.2. Adults
13.3. Geriatrics
13.4. Pediatrics
14. Americas Addison's Disease Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Addison's Disease Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Addison's Disease Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. F. Hoffmann-La Roche Ltd
17.3.2. Abbott Laboratories
17.3.3. Siemens Healthineers AG
17.3.4. Danaher Corporation
17.3.5. Thermo Fisher Scientific Inc.
17.3.6. bioMérieux SA
17.3.7. Ortho Clinical Diagnostics, Inc.
17.3.8. DiaSorin S.p.A.
17.3.9. Bio-Rad Laboratories, Inc.
17.3.10. Fujirebio Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ADDISON'S DISEASE TESTING MARKET MULTI-CURRENCY
FIGURE 2. ADDISON'S DISEASE TESTING MARKET MULTI-LANGUAGE
FIGURE 3. ADDISON'S DISEASE TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ADDISON'S DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ADDISON'S DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ADDISON'S DISEASE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ACTH STIMULATION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY CORTISOL MEASUREMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DEXAMETHASONE SUPPRESSION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY INSULIN-INDUCED HYPOGLYCEMIA TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SECONDARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY AUTOMATED METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY MANUAL METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY STIMULATED SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY WHOLE SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ADDISON'S DISEASE TESTING MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ADDISON'S DISEASE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 69. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 71. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 73. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 74. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 75. CANADA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 81. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 84. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 85. MEXICO ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 127. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 130. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 132. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 135. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 136. GERMANY ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 137. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 140. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 142. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 145. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 146. FRANCE ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 157. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 160. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 162. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 164. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 165. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 166. ITALY ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 167. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 170. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 172. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 174. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 175. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 176. SPAIN ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 207. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 210. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 212. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 214. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 215. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 216. DENMARK ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 227. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 228. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 230. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 232. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 234. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 235. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 236. QATAR ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 237. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 238. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 240. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 242. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 244. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 245. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 246. FINLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 267. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 268. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 270. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 271. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 272. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 274. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 275. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 276. EGYPT ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 277. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 278. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 280. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 282. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 284. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 285. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 286. TURKEY ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 297. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 298. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 300. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 301. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 302. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 304. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 305. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 306. NORWAY ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 307. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 308. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 310. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 311. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 312. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 314. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 315. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 316. POLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY LAB-BASED, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY SALIVA, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND ADDISON'S DISEASE TESTING MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 327. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC ADDISON'S DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC AD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Addison's Disease Testing market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Ortho Clinical Diagnostics, Inc.
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories, Inc.
  • Fujirebio Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 277.42 Million
Forecasted Market Value ( USD ) by 2030 $ 336.54 Million
Compound Annual Growth Rate3.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Addison's Disease Treatment Market by Treatment Type, Administration Route, End User, Distribution Channel, Age Group - Global Forecast to 2030 - Product Image

Addison's Disease Treatment Market by Treatment Type, Administration Route, End User, Distribution Channel, Age Group - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Addison's Disease Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Addison's Disease Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 187 Pages
  • Global
From
Addison's Disease Global Market Report 2025 - Product Image

Addison's Disease Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Addison's Disease Therapeutics - Global Strategic Business Report - Product Image

Addison's Disease Therapeutics - Global Strategic Business Report

  • Report
  • 278 Pages
  • Global
From
Addisons Disease Therapeutics Market 2024-2028 - Product Image

Addisons Disease Therapeutics Market 2024-2028

  • Report
  • 166 Pages
  • Global
From

About the Addison Disease Testing Market

Addison Disease Testing is a diagnostic test used to detect the presence of Addison Disease, an endocrine disorder caused by the body's inability to produce enough of the hormones cortisol and aldosterone. The test is typically performed by measuring the levels of cortisol and aldosterone in the blood, urine, or saliva. It may also include imaging tests such as CT scans or MRI scans. The Addison Disease Testing market is a growing segment of the diagnostics industry, as the prevalence of the disease is increasing. The market is driven by the increasing awareness of the disease, the availability of advanced diagnostic technologies, and the rising demand for early diagnosis and treatment. Some of the major players in the Addison Disease Testing market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Bio-Rad Laboratories, and Quest Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.